Profile
Kitty Yale formerly worked at Gilead Sciences, Inc., as Vice President-Clinical Operations from 2001 to 2018, Roche Global Development, as Senior Clinical Research & Operations, and Akero Therapeutics, Inc., as Chief Development Officer from 2018 to 2025.
Ms. Yale received her undergraduate degree from Glasgow Caledonian University.
Former positions of Kitty Yale
| Companies | Position | End |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Corporate Officer/Principal | 09/12/2025 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/10/2018 |
Roche Global Development | Corporate Officer/Principal | - |
Training of Kitty Yale
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Glasgow Caledonian University
Glasgow Caledonian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Global Development | |
Akero Therapeutics, Inc.
Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Kitty Yale
















